
American College of Cardiology - ACC
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American College of Cardiology - ACC — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
American College of Cardiology (ACC) Annual Scientific Session — ACC.26 (March 28–30, 2026)
Official event basics (from the ACC website)
- Event: ACC.26 — Annual Scientific Session
- Dates: March 28–30, 2026
- Venue: (Not stated in the provided page text)
- City/Region: New Orleans, LA
- Country: United States
ACC.26 is positioned by the American College of Cardiology as a large, global gathering of cardiovascular professionals, with both in-person and virtual participation. The program coverage and attendee communications emphasize learning pathways, poster content, and ACC Anywhere on-demand access.
1️⃣ Who attends (BUYERS / ATTENDEES)
ACC.26 is a high-specialization medical meeting, so the attendee mix is strongly weighted toward clinical leaders and healthcare professionals—while commercial and institutional decision-makers tend to appear via roles tied to cardiovascular care, research, education, and commercial strategy in cardiology.
Primary attendee groups (clinical & academic):
- Cardiologists and cardiovascular specialists (general cardiology, interventional cardiology, electrophysiology)
- Physician-scientists and academic faculty (universities, medical schools)
- Advanced practice clinicians working in cardiology care delivery
- Researchers presenting and viewing posters across many topics (the site highlights extensive poster hall content)
- Clinical educators and program leaders who influence continuing medical education (CME) adoption and learning pathways
Commercial & buyer-like stakeholders (industry decision influencers):
- Pharmaceutical and biotechnology commercial leadership (cardiovascular franchises)
- Medical affairs professionals (clinical science, publications, evidence planning, KOL engagement)
- Health economics / outcomes research teams and real-world evidence stakeholders
- Clinical education and training stakeholders tied to product education and cardiology guideline implementation
- Diagnostics, imaging, and cardiovascular device strategy teams (where relevant)
- Research operations / grants / clinical trials leaders focused on cardiovascular R&D
For attendee-list research and targeting, we recommend treating ACC.26 as a cardiology knowledge ecosystem where “buyers” typically align with teams that (a) market or position cardiovascular products, (b) manage evidence generation and medical education, and (c) influence clinical adoption through scientific engagement.
2️⃣ Where the show is happening + attendee geographic origin
Show location (city/country): New Orleans, Louisiana, United States.
The page text provided does not specify the venue name; however, it clearly confirms the meeting city and dates.
Attendee geographic origin (global orientation):
- Primary origin: United States cardiovascular professionals
- Strong secondary origin: International participants (the ACC website explicitly describes participation by “thousands of cardiovascular professionals from around the globe”)
- Expected pattern: International representation typically clusters around major research institutions and global pharma/device companies with established clinical operations in the U.S.
Best geographic targeting strategy: United States + “global cardiology” (EMEA, APAC, and Canada) for buyer roles in medical affairs, clinical education, evidence generation, and cardiovascular commercial leadership.
3️⃣ Audience reach (Local / National / Global)
ACC.26 is best categorized as global in audience reach.
- Global learning ecosystem: The event is described as drawing cardiovascular professionals “from around the globe.”
- In-person plus virtual: ACC highlights virtual access and on-demand sessions via ACC Anywhere.
- Global content depth: The site references thousands of posters and multiple learning pathways, indicating breadth across subspecialties and clinical interests.
4️⃣ Sample buyer company names (BUYERS ONLY) + Websites (15–20 rows)
Below are buyer-style target companies that are commonly active in cardiovascular education, medical affairs, cardiology evidence programs, and cardiovascular product ecosystems. These should be validated in your final list pull based on your client’s exact product category.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Abbott | https://www.abbott.com | Director, Cardiovascular Medical Affairs | VP, Cardiovascular Marketing | Active in cardiovascular technology and evidence-driven positioning; likely to engage at major cardiology scientific meetings with medical affairs and franchise leadership. |
| 2 | Medtronic | https://www.medtronic.com | Senior Director, Cardio Medical Affairs | Product Marketing Director, Cardiac Rhythm/Devices | Large cardiovascular device portfolio; typically invests in scientific engagement and clinical education across cardiology subspecialties. |
| 3 | Boston Scientific | https://www.bostonscientific.com | Director, Interventional Cardiology Marketing | Head of Medical Affairs (Cardiology) | Common presence in cath-lab and interventional cardiology ecosystems; buyer roles align with clinical strategy, evidence, and education. |
| 4 | Johnson & Johnson (J&J) | https://www.jnj.com | Medical Science Liaison Manager | VP, Therapeutic Area Marketing (Cardiovascular) | Cardiovascular portfolio organizations often participate in top cardiology congresses for medical education and clinical positioning. |
| 5 | Pfizer | https://www.pfizer.com | Associate Director, Cardiovascular Medical Affairs | Director, Evidence Generation | Cardiovascular franchise teams benefit from high-quality KOL engagement and poster/scientific pathway exposure. |
| 6 | Merck & Co., Inc. | https://www.merck.com | Director, Cardiovascular Medical Affairs | Head of Clinical Operations (CV) | Evidence and outcomes-focused teams align well with major cardiology scientific sessions and poster-driven discovery. |
| 7 | Roche | https://www.roche.com | Medical Affairs Lead, Cardiology | Global Marketing Director (Therapeutic Area) | Strong medical education and clinical science footprint; likely to engage with cardiovascular specialists for evidence and adoption. |
| 8 | Novartis | https://www.novartis.com | Cardiovascular Medical Affairs Director | Global Brand Lead, CV/Heart | Cardiovascular focus organizations typically target guideline-relevant learning pathways and evidence-based messaging. |
| 9 | Sanofi | https://www.sanofi.com | Director, Cardiovascular Medical Affairs | Therapeutic Area Marketing Lead | Therapeutic area commercial leadership often aligns with major professional congress attendance and KOL engagement strategy. |
| 10 | AstraZeneca | https://www.astrazeneca.com | Senior Manager, Cardiovascular Medical Affairs | Market Access & Evidence Director | Cardiovascular teams frequently prioritize scientific conferences for clinical credibility and evidence-based stakeholder engagement. |
| 11 | Bayer | https://www.bayer.com | Cardiology Portfolio Medical Affairs Director | Director, Clinical Evidence | Buyer roles typically span evidence generation, clinical science, and medical education—well suited to ACC-style sessions and poster halls. |
| 12 | Amgen | https://www.amgen.com | Director, Cardiovascular Medical Affairs | Head of Clinical Trials (CV) | Evidence-first clinical teams and medical affairs stakeholders commonly engage in large cardiology meetings. |
| 13 | Gilead Sciences | https://www.gilead.com | Medical Affairs Manager (Therapeutic Area) | Director, Clinical Evidence Strategy | Buyer fit when cardiovascular-adjacent therapeutic areas and evidence roadmaps align with cardiology stakeholders. |
| 14 | GE HealthCare | https://www.gehealthcare.com | Cardiology Imaging Sales Director | Clinical Specialist Manager (CV Imaging) | Imaging and cardiology diagnostic ecosystem stakeholders often seek conference visibility and clinical education engagement. |
| 15 | Siemens Healthineers | https://www.siemens-healthineers.com | Cardiology Solutions Marketing Director | Clinical Application Specialist (Cardiac Imaging) | Cardiac imaging and diagnostic solutions are naturally aligned with cardiology scientific meetings and evidence-led workflows. |
| 16 | Philips | https://www.philips.com | Director, Cardiology Informatics | Product Marketing Lead (Patient Monitoring/Imaging) | Cardiovascular care technology stakeholders benefit from conference engagement around care delivery, monitoring, and clinical pathways. |
| 17 | IQVIA | https://www.iqvia.com | Director, Real-World Evidence (CV) | Head of Clinical Data Solutions | RWE and evidence-generation buyers align strongly with poster ecosystems and learning pathways where clinical stakeholders need actionable evidence. |
| 18 | Fortrea | https://www.fortrea.com | Senior Director, Clinical Operations | Director, Clinical Research (CV) | Clinical research and trial support organizations often target high-impact scientific meetings for sponsor and investigator relationships. |
| 19 | IQVIA / Data & Analytics (Alternative listing) | https://www.iqvia.com | Global Director, Therapeutic Area Insights (CV) | Consulting Director (Healthcare) | Insights and analytics buyers fit when the client provides evidence, dashboards, analytics, or trial-enablement solutions for cardiovascular markets. |
| 20 | Cardiovascular Education / CME Platforms (Example category) | (Client-specific) | Director, Professional Education | Head of CME Strategy | If your client product supports medical education, ACC’s learning pathways and on-demand content environment indicates strong relevance. |
Top 5 best buyer samples to start with (general cardiology fit): Abbott, Medtronic, Boston Scientific, Pfizer, and Roche.
5️⃣ Job profiles, industries & event type
Best job profiles to target (for attendee-list research and outreach segmentation):
- Cardiovascular Medical Affairs Director/Lead
- Medical Science Liaison (MSL) Manager / MSL Program Lead
- Evidence Generation Director / Real-World Evidence Lead
- Clinical Trials / Clinical Operations Lead (CV-focused teams)
- Interventional Cardiology Marketing Director
- Therapeutic Area Marketing Lead (Cardiovascular)
- Market Access / Outcomes Research Director
- Cardiac Imaging / Diagnostics Solutions Marketing Director (if device/imaging is relevant)
- Professional Education / CME Strategy Director (if the client offers training/education/content)
- Research Grants & KOL Engagement Leadership
Industries that typically align (using the provided industry taxonomy):
- Pharmaceuticals
- Medical Devices
- Hospital & Health Care
- Biotechnology
- Health, Wellness & Fitness
- Research
- Market Research
- Outsourcing/Offshoring (if the client is CRO/clinical services)
- Information Technology & Services (if the client provides healthcare data/AI platforms)
- E-Learning (if the client sells medical education or learning platforms)
- Events Services (only if the client provides specialized event education formats)
Event type classification:
- Medical/Healthcare Conference
- Professional Scientific Congress
- CME / Continuing Education ecosystem
- Poster & learning pathway-driven knowledge exchange
- Cross-disciplinary cardiovascular stakeholder meeting (clinical, academic, industry medical affairs)
6️⃣ Estimated attendance (expected total footfall)
The provided ACC page text does not include a specific attendance number (e.g., total footfall, in-person attendee count, or exhibit hall size). Therefore, we cannot reliably state an “expected total footfall” figure from the supplied source text.
Requested next step: If we can access another ACC.26 page that lists attendance/exhibitors/meeting size, we can calculate a tighter estimate for your planning and outreach prioritization.
7️⃣ Key focus areas & buyer engagement
Key focus areas suggested by the ACC.26 meeting format (from the provided page text):
- Cardiovascular education across multiple learning pathways (the site references “11 learning pathways” in the virtual Poster Hall content)
- Large poster volume and research dissemination (the site references 4,500+ posters across learning pathways)
- On-demand scientific learning experience via ACC Anywhere (200+ sessions from ACC.26 on-demand for attendees)
- Global medical community connection (“thousands of cardiovascular professionals from around the globe came together”)
How to engage “buyer-like” roles effectively (recommended messaging angles):
- Evidence + clinical learning alignment: position the client offering as supporting clinicians with better evidence synthesis, education, or research enablement.
- KOL and medical affairs relevance: tailor outreach to medical affairs leaders and clinical education stakeholders who care about scientific credibility.
- Poster/learning pathway readiness: if the client supports outcomes research, RWE, analytics, imaging workflows, or professional education, emphasize how their solution maps to poster-driven learning and subspecialty pathways.
- Global reach narrative: align the pitch to U.S. + international cardiology stakeholders and global franchise teams.
8️⃣ Client-product fit note + buyer list sourcing logic (we need your client website)
To recommend the best buyer titles and the best-fit company segments for ACC.26 based on your client’s exact product requirements, we need the client website.
Please share:
- Your client website URL
- Product category (e.g., medical device, imaging software, RWE analytics, CME content platform, CRO services, clinical education, recruitment, etc.)
- Target buyer geography (U.S. only vs global)
In the meantime, here is how we will map buyers to your client (once we see the website):
- If the client sells medical devices or cardiac monitoring/imaging tools, we will prioritize device and imaging leaders (medical affairs, product marketing, cardiology solutions).
- If the client sells pharma/biotech-grade evidence services, we will prioritize evidence generation, outcomes research, RWE, and clinical operations roles.
- If the client sells professional education / e-learning / CME-related platforms, we will prioritize CME strategy, professional education directors, and medical learning operations.
- If the client sells clinical research / CRO services, we will prioritize clinical operations, trial management, and research leadership in cardiovascular studies.
- If the client sells healthcare data/analytics platforms, we will prioritize therapeutic area insights, RWE teams, and healthcare informatics leadership.
After we receive the client website, we will deliver a refined buyer shortlist aligned to your requirements and remove any mismatched categories from the sample list above.
9️⃣ Suggested industries (from the provided industry list)
Based on ACC.26 being a cardiology scientific meeting with poster-driven clinical education and global stakeholder participation, the most relevant industry filters from your provided taxonomy typically include:
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Hospital & Health Care
- Research
- Market Research
- E-Learning (if education/content is part of the product)
- Information Technology & Services (if software/data platforms are part of the product)
- Outsourcing/Offshoring (if CRO/clinical services are part of the product)
- Events Services (only when the client provides healthcare event education or conference services)
Quality scoring & positioning recommendation
Quality rating (for B2B attendee-list research and buyer segmentation): 8/10 (with one condition).
The condition is that we must filter precisely by industry buyer roles (medical affairs, evidence generation, clinical education, market access, and clinical operations) rather than only general attendee populations. ACC.26 has a strong scientific/clinical base, so the buyer value concentrates in specific functional titles.
Next deliverable we can produce (once you share the client website)
- A refined “Best Title to Target” list tailored to your product category
- A prioritized buyer company set (U.S. + global) matched to your client’s ICP
- A final sample table (15–20 rows) that matches your exact requirements
- Recommended industry filter mapping using your taxonomy list
Please share your client website URL so we can identify the “best buyers” for ACC.26 based on your specific product fit, and then finalize the most accurate company-title targeting.
Data sheet
| Event Name | ACC.27 Together With WCC |
| Event Date | April 10 – 12, 2027 |
| Event Status | Upcoming |
| Venue | George R Brown Convention Center |
| City | Houston |
| State / Region | Texas |
| Country | United States |
| Organizer | American College of Cardiology Foundation / American College of Cardiology |
| Official Event Website | accscientificsession.acc.org |
| Event Type | Annual scientific session, medical congress, exhibition and professional education event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Thousands of cardiovascular professionals. Exact 2027 attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Historical / prior-year evidence from the official website. No exact 2027 attendance total published in the supplied source. |
| Main Purpose of Event | Professional education, clinical research dissemination, networking, medical innovation showcase, and industry engagement for cardiovascular care stakeholders. |
ACC.27 Together With WCC is the upcoming annual scientific session associated with the American College of Cardiology, scheduled in Houston for April 10–12, 2027. Based on the official event site, the meeting brings together cardiovascular professionals from around the globe and includes scientific programming, poster presentations, continuing education activity, and expo-related participation.
From a commercial and partnership standpoint, this event matters because it attracts a concentrated audience of cardiology clinicians, researchers, academic institutions, hospital decision-makers, professional societies, and medical industry stakeholders. It is particularly relevant for companies selling clinical technologies, diagnostics, medical devices, pharmaceuticals, research tools, digital health platforms, education solutions, and healthcare partnership services.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Cardiologists and physician leaders | Hospitals, health systems, specialty cardiovascular groups, academic medical centers | Clinical influence, product evaluation, adoption recommendations, protocol leadership | High-value clinical buyers and influencers for devices, diagnostics, software, and therapies |
| Hospital procurement and supply chain teams | Hospital systems, integrated delivery networks, academic medical centers | Vendor selection, contract management, sourcing, budget review | Critical for conversion from clinical interest to purchase and rollout |
| Clinical researchers and principal investigators | Universities, teaching hospitals, research institutes | Trial participation, evidence generation, publication support | Important for research collaborations, trial-site recruitment, and validation |
| Healthcare executives and service line leaders | Hospital systems, cardiovascular institutes, ambulatory networks | Capital approval, strategic expansion, partnership decisions | Relevant for enterprise sales, pilots, and strategic partnerships |
| Pharmaceutical and medical device business units | Drug makers, device manufacturers, cardiovascular solution providers | Market intelligence, KOL engagement, channel partnerships | High relevance for co-marketing, distribution, evidence, and clinician outreach |
| Digital health, imaging and clinical IT leaders | Health systems, imaging centers, telehealth programs, specialty clinics | Technology evaluation, interoperability review, implementation decisions | Relevant for SaaS, analytics, workflow, AI, and remote monitoring vendors |
| Professional education and accreditation participants | Medical societies, CME providers, academic departments | Program design, educational partnerships, content sponsorship | Useful for content-led engagement and long-cycle relationship building |
| Media and scientific communications stakeholders | Medical news platforms, journals, communications agencies | Visibility, product announcements, trial dissemination | Valuable for launch amplification and thought leadership |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Houston | Local hospital systems, Texas Medical Center institutions, local clinicians and administrators | High | Strong concentration of healthcare providers, research institutions, and cardiovascular care networks |
| Texas | Regional attendees from major health systems in Houston, Dallas-Fort Worth, Austin, San Antonio and surrounding markets | High | Texas supports large hospital networks and major cardiovascular treatment centers |
| Southern United States | Clinicians, researchers, and healthcare executives from nearby states | Medium to High | Houston is a practical access point for southern and central U.S. attendees |
| United States national market | National physician, hospital, academic, and industry attendance | Very High | ACC is a leading national cardiology organization with broad domestic reach |
| International | Global cardiovascular professionals and organizations | High | Official site states participants come from around the globe; WCC co-branding further supports international appeal |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website states that thousands of cardiovascular professionals from around the globe came together for the annual session, indicating established international reach. |
| National | Secondary reach | As the flagship annual scientific session of a major U.S. cardiology association, domestic attendance and U.S. institutional participation are expected to be substantial. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| American College of Cardiology | Organizer / professional association | Core event organizer and central stakeholder for sponsorship, education, partnership and exhibitor opportunities | acc.org | Director, Industry Relations; Sponsorship Manager; Meetings Director; Partnership Director | Confirmed Current-Year Participant |
| World Congress of Cardiology | Co-branded scientific congress stakeholder | Included in the official save-the-date branding for ACC.27, indicating international congress relevance | world-heart-federation.org | Congress Director; Partnerships Director; Scientific Program Lead | Confirmed Current-Year Participant |
| Current-year buyer organization list not publicly confirmed in supplied source | Data availability note | The supplied official website text confirms event timing and global audience, but does not publish a current-year attendee, speaker-organization, exhibitor, sponsor, or buyer-company list. | — | — | Confirmed Government / Procurement Organization |
| Additional buyer-company profiling recommended after official exhibitor/speaker/agenda release | Research recommendation | Best practice is to append confirmed health systems, universities, device makers, and sponsor organizations once official 2027 participation materials are published. | — | Procurement Director; Cardiology Service Line Director; VP Supply Chain; Research Partnerships Lead | Prior-Year Participation Evidence |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief of Cardiology / Cardiovascular Service Line Leader | Clinical Leadership | C-Level / Executive / Director | High influence on technology adoption, care pathways and departmental priorities |
| 2 | Director of Procurement | Procurement | Director | Controls sourcing process, vendor selection, and commercial approval |
| 3 | Strategic Sourcing Manager | Supply Chain / Procurement | Manager | Evaluates vendor options and contract frameworks |
| 4 | VP Supply Chain | Supply Chain | VP | Approves enterprise purchasing strategies and systemwide standardization |
| 5 | Medical Director, Cardiology | Clinical Operations | Director | Shapes clinical adoption and peer influence |
| 6 | Clinical Research Director | Research | Director | Important for study partnerships, trial tools and research solutions |
| 7 | Chief Medical Information Officer | IT / Clinical Informatics | C-Level | Key stakeholder for digital health, imaging, workflow and interoperability tools |
| 8 | Partnerships Director | Business Development | Director | Relevant for co-development, sponsorship, education and channel relationships |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core institutional audience for cardiovascular care | Health system buyers, clinicians, procurement teams |
| 2 | Medical Devices | Highly relevant to cardiology diagnostics, implants, monitoring and interventional technologies | Device partnerships, clinical evaluation, product launch support |
| 3 | Pharmaceuticals | Cardiovascular drug makers are common partners in this ecosystem | Medical affairs, sponsorship, education, evidence dissemination |
| 4 | Biotechnology | Relevant for translational cardiovascular science and trial partnerships | Research tools, biomarker solutions, collaboration sourcing |
| 5 | Research | Strong fit for universities, institutes, and clinical research centers | Study collaboration, poster engagement, scientific outreach |
| 6 | Higher Education | Academic medicine and teaching hospitals are likely represented | Faculty outreach, training partnerships, clinical programs |
| 7 | Information Technology & Services | Relevant for clinical workflow, interoperability and digital health tools | Hospital IT buyers and integration stakeholders |
| 8 | Computer Software | Supports analytics, imaging, remote monitoring and education platforms | SaaS demos, workflow optimization, physician engagement platforms |
| 9 | Health, Wellness & Fitness | Relevant for prevention, rehabilitation, remote patient engagement and lifestyle solutions | Preventive cardiology and patient-support programs |
| 10 | Nonprofit Organization Management | Professional societies and foundations operate in this event ecosystem | Education, advocacy, fundraising and awareness partnerships |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Thousands | Historical / prior-year evidence | Official site states “Thousands of cardiovascular professionals from around the globe” attended ACC.26 | No exact 2027 attendance total publicly confirmed |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Supplied source references an Expo section but gives no count | Await official exhibitor prospectus or directory |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer-specific data in supplied official text | Medical congresses typically do not publish separate buyer counts |
| Speaker count | Not publicly confirmed | Unconfirmed | Faculty & Presenters is referenced, but count not included in supplied text | Poster and faculty participation likely substantial |
| Poster volume | 4,500+ posters | Confirmed historical evidence | Official website text for ACC.26 virtual Poster Hall | Strong indicator of large scientific participation |
| On-demand session volume | 200+ ACC.26 sessions; 5,000+ videos in ACC Anywhere library | Confirmed historical evidence | Official event website text | Shows strong content depth and year-round engagement potential |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Cardiovascular clinical innovation | Improved patient outcomes, evidence-backed therapies, new treatment options | Clinical demos, KOL meetings, poster engagement, scientific sessions | Devices, diagnostics, therapeutics, monitoring systems |
| Medical education and CME | Accredited learning, practice updates, guideline implementation | Sponsored education, digital content, faculty support | Education platforms, content partnerships, grant support |
| Clinical research | Trial collaboration, data collection, evidence generation | Research meetings, investigator outreach, abstract support | Research software, CRO support, data tools, registry solutions |
| Digital transformation | Workflow efficiency, remote monitoring, interoperability, analytics | IT leadership meetings, workflow ROI discussions | SaaS, EHR integration, imaging software, AI-enabled analytics |
| Hospital procurement and standardization | Cost control, vendor consolidation, quality assurance | Procurement meetings, value analysis discussions, pilot offers | Contract-based supply, service models, bundled solutions |
| Scientific visibility and brand credibility | Thought leadership, peer validation, launch support | Symposia, abstracts, advisory boards, media touchpoints | Scientific communications, PR, congress sponsorship packages |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for medical technology, pharma, healthcare services, research, and clinical software sellers |
| Decision-maker availability | High | Clinical leaders and institutional influencers are likely present, though exact attendee roster is not yet public |
| Data collection potential | Medium | Good event relevance, but current-year participant-level data is limited in the supplied source |
| Apollo targeting potential | Very High | Clear industry, title, department and geography filters can be built around cardiology and hospital buying centers |
| Geographic targeting potential | High | Houston and Texas offer strong regional targeting, while the event also supports national and international segmentation |
| Best outreach approach | High | Use education-led, evidence-led and clinical-value messaging rather than generic sales outreach |
| Overall lead quality | High | Excellent event for healthcare and cardiology-focused pipeline development, especially for high-consideration B2B offerings |
| Best use case | High | Account-based outreach, sponsorship strategy, exhibitor targeting, speaker-org mapping and hospital prospecting |
| Limitations / risks | Medium | Current-year confirmed attendee and buyer-company data is not yet public in the supplied source, limiting participant-level certainty |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software; Health, Wellness & Fitness; Nonprofit Organization Management | Capture the most relevant healthcare, academic and industry buyer pools |
| Departments | Procurement, Supply Chain, Clinical Operations, Medical Affairs, Research, Information Technology, Business Development, Partnerships | Focus on both economic and clinical decision-makers |
| Seniority | C-Level, VP, Director, Head, Manager | Prioritize budget owners and implementation influencers |
| Job titles | Chief of Cardiology, Medical Director Cardiology, Cardiovascular Service Line Director, Director of Procurement, Strategic Sourcing Manager, VP Supply Chain, Chief Medical Information Officer, Clinical Research Director, Partnerships Director, Medical Affairs Director | Direct outreach to target roles most likely to influence cardiology-related purchases |
| Geography | Houston; Texas; United States; selected international cardiology hubs where relevant | Layer local event capture with national account expansion |
| Employee size | 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,001+ | Focus on hospitals, health systems, universities, and major industry sponsors with buying capacity |
| Keywords | cardiology, cardiovascular, heart institute, electrophysiology, interventional cardiology, imaging, structural heart, clinical trials, CME, digital health, remote monitoring | Narrow results to event-relevant specialties and use cases |
| Technologies, if relevant | EHR integration, remote monitoring, imaging platforms, clinical analytics, telehealth | Useful for software, AI and health IT vendors |
| Revenue range, if relevant | Mid-market to enterprise healthcare accounts | Supports prioritization of scalable, contract-capable targets |
| Company type | Hospitals, academic medical centers, healthcare systems, device manufacturers, pharma companies, research institutions, associations | Align outreach by buyer model and sales motion |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ACC Scientific Session Official Website | Official event website | Confirmed ACC.27 Together With WCC branding, Houston location, April 10–12, 2027 dates, global audience wording, ACC.26 historical references, poster volume and on-demand session references | Very High |
| User-supplied event details | Provided input | Venue listed as George R Brown Convention Center; city, state and country details | Medium |
| ACC.org | Official organizer website | Organizer identity and ACC institutional ownership context | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American College of Cardiology - ACC — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.